The Effect of 5-Aminolevulinic Acid on Intraoperative Hypotension in Brain Tumor Patients

Impact of 5-Aminolevulinic Acid on the Risk of Intraoperative Hypotension in Patients with Brain Tumors - The 5-ALA test

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000054939

Enrollment

500

Registered

2024-07-11

Start date

2024-08-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High-grade glioma, Low-grade glioma, Malignant lymphoma, Metastatic brain tumor, Meningioma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who underwent intracranial tumor resection for high-grade glioma, malignant lymphoma, metastatic brain tumor, meningioma, or low-grade glioma at the Jikei University Kashiwa Hospital between January 2015 and October 2025.

Exclusion criteria

Exclusion criteria: Emergency surgery Age under 18 years Preoperative dialysis or vasopressor use Missing data Patients who declined to participate in the study

Design outcomes

Primary

Measure	Time frame
The incidence of intraoperative hypotension	—

Secondary

Measure	Time frame
Intensity of hemodynamic management Severity of intraoperative hypotension Incidence of postoperative complications	—

Countries

Japan

Contacts

Public ContactKazuma Oshida

The Jikei University School of Medicine Kashiwa Hospital Department of Anesthesiology

yensid.725@jikei.ac.jp04-7164-1111

Outcome results